These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25798836)

  • 1. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
    Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
    Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIS21
    Lim IK; Choi JA; Kim EY; Kim BN; Jang S; Ryu MS; Shim SH
    Cell Signal; 2017 Jan; 30():179-190. PubMed ID: 27932314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIS21
    Sundaramoorthy S; Devanand P; Ryu MS; Song KY; Noh DY; Lim IK
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1445-1462. PubMed ID: 29808317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells.
    Choi JA; Lim IK
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1657-65. PubMed ID: 23907596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
    Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
    Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1.
    Devanand P; Kim SI; Choi YW; Sheen SS; Yim H; Ryu MS; Kim SJ; Kim WJ; Lim IK
    FEBS J; 2014 Dec; 281(24):5581-601. PubMed ID: 25284287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
    Imran M; Lim IK
    Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.
    Quy LN; Choi YW; Kim YH; Chwae YJ; Park TJ; Lim IK
    Cell Signal; 2013 Dec; 25(12):2391-9. PubMed ID: 23917204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2
    Devanand P; Oya Y; Sundaramoorthy S; Song KY; Watanabe T; Kobayashi Y; Shimizu Y; Hong SA; Suganuma M; Lim IK
    Exp Mol Med; 2018 Feb; 50(2):e449. PubMed ID: 29472702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
    Tirone F
    J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
    Imran M; Park TJ; Lim IK
    Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
    Lim YB; Park TJ; Lim IK
    J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
    Lim IK
    J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes.
    Micheli L; Ceccarelli M; Farioli-Vecchioli S; Tirone F
    J Cell Physiol; 2015 Dec; 230(12):2881-90. PubMed ID: 25967096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
    Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
    Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells.
    Zubair H; Lim IK; Safi SZ; Rehman F; Imran M
    Ann Clin Lab Sci; 2020 Nov; 50(6):711-716. PubMed ID: 33334784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell translocation gene 2 mediates crosstalk between PI3K/Akt1 and NFκB pathways which enhances transcription of MnSOD by accelerating IκBα degradation in normal and cancer cells.
    Sundaramoorthy S; Ryu MS; Lim IK
    Cell Commun Signal; 2013 Sep; 11():69. PubMed ID: 24047462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of B-cell translocation gene 2 protein in normal human tissues.
    Melamed J; Kernizan S; Walden PD
    Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression.
    Micheli L; D'Andrea G; Leonardi L; Tirone F
    J Cell Physiol; 2017 Jul; 232(7):1696-1707. PubMed ID: 27333946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
    Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
    Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.